Mangoceuticals, Inc. (MGRX) Free cash flow 2023–2024
Mangoceuticals, Inc. (MGRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.9MFY2024 · since FY2023: -$7.0M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.9M | +30.9% |
| FY2023 | -$7.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MGRX financial trends
MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating marginMGRX Operating cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX Shareholders’ equityMGRX overview →